SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-005900
Filing Date
2024-02-28
Accepted
2024-02-28 16:15:25
Documents
16
Period of Report
2024-02-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20240228_8k.htm   iXBRL 8-K 33242
2 EXHIBIT 4.2 ex_632210.htm EX-4.2 23614
  Complete submission text file 0001437749-24-005900.txt   194285

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crvo-20240226.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20240226_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20240226_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20240226_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT crvo20240228_8k_htm.xml XML 2819
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 24695560
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)